Thomas Ginko

Title: Thomas Ginko: Innovator in Crystalline Forms

Introduction

Thomas Ginko is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals through his innovative work on crystalline forms of specific compounds. His expertise and dedication to research have led to advancements that are beneficial in medicinal applications.

Latest Patents

Ginko holds a patent for "Crystalline forms of 11β-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17α-pregna-4,9-dien-3-one." This invention focuses on two crystalline forms, specifically polymorphs I and II, which are essential for the development of medicinal products. The patent also discusses the preparation processes for these polymorphs, including displacement crystallization and trituration methods.

Career Highlights

Ginko is associated with Bayer Schering Pharma AG, a leading company in the pharmaceutical industry. His work has been instrumental in enhancing the understanding and application of crystalline forms in drug development. With a total of 1 patent, he has established himself as a valuable contributor to the field.

Collaborations

Throughout his career, Ginko has collaborated with esteemed colleagues such as Wolfgang Beckmann and Gabriele Winter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Thomas Ginko's contributions to the field of pharmaceuticals through his patent on crystalline forms demonstrate his commitment to innovation. His work not only advances scientific knowledge but also has practical implications for the development of medicinal products.